Pustular Psoriasis

• CLINICAL_TRIALS trial_result · 2026-02-24
  Clinical Trial Update: Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.

  The clinical trial evaluating an AI diagnostic tool for primary care doctors assessing skin conditions has been completed. The study evaluat…

• CLINICAL_TRIALS trial_result · 2026-02-24
  Clinical Trial Update: Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists

  A completed clinical trial evaluating Legit.Health Plus Support as a diagnostic aid for generalized pustular psoriasis and other skin condit…

• CLINICAL_TRIALS trial_result · 2025-06-19
  Clinical Trial Update: Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis)

  Pfizer's infliximab biosimilar was studied in a Drug Use Investigation for psoriasis indications; the trial has completed and results were p…

• CLINICAL_TRIALS trial_result · 2023-08-25
  Clinical Trial Update: A Phase 3 Clinical Study of KHK 4827 [Phase 3]

  Phase 3 trial update for KHK 4827 across psoriasis-related conditions; study completed.

• CLINICAL_TRIALS trial_result · 2021-04-30
  Clinical Trial Update: Anakinra for Inflammatory Pustular Skin Diseases [Phase 2]

  Phase 2 trial update on anakinra for inflammatory pustular skin diseases (Sneddon-Wilkinson, Acrodermatitis Continua of Hallopeau) with comp…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2019-12-09
  Clinical Trial Update: A Phase 4 Clinical Study of Brodalumab [Phase 4]

  A Phase 4 clinical study of brodalumab completed, investigating psoriasis vulgaris and psoriatic arthritis (with related pustular and erythr…

• CLINICAL_TRIALS trial_result · 2019-10-24
  Clinical Trial Update: An Efficacy and Safety Study of CNTO1959 (Guselkumab) in the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis [Phase 3]

  Phase 3 clinical trial update for guselkumab (CNTO1959) in generalized pustular psoriasis and erythrodermic psoriasis has completed.